Testing effectiveness (Phase 2)UnknownNCT03691051
What this trial is testing
Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer
Who this might be right for
HER2 Positive Metastatic Breast Cancer
Henan Cancer Hospital 78